Twice-Yearly shot for HIV prevention put to the test in major US study
NCT ID NCT07473778
Summary
This study aims to see how well people in real-world clinics stick with a long-acting injectable drug called lenacapavir to prevent HIV. It will follow 3000 people across the United States for up to two years to understand how they start, use, and sometimes stop this prevention method. The main goal is to see how many people are still getting their injections on time after one year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.